Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
05/2002
05/30/2002US20020065418 Viral polymerase inhibitors
05/30/2002US20020065415 For treating cerebral ischemia or cerebral infarction resulting from thromboembolic or hemorrhagic stroke, cerebral vasospasms, hypoglycemia, cardiac arrest, neurodegenerative disorders
05/30/2002US20020065308 EP4 receptor selective agonists in the treatment of osteoporosis
05/30/2002US20020065307 Novel benzimidazole derivatives
05/30/2002US20020065305 As antitumor agent
05/30/2002US20020065289 Amino pyrazole derivatives useful for the treatment of obesity and other disorders
05/30/2002US20020065285 Aromatic heterocyclic compounds as antiinflammatory agents
05/30/2002US20020065276 N-triazolymethyl-piperazine compounds with neurokinin-receptor antagonist activity
05/30/2002US20020065270 For use in therapy of inflammatory diseases such as, for example, rheumatoid arthritis
05/30/2002US20020064794 Modified carbocyanine dyes and their conjugates
05/30/2002US20020064782 Fluorescent nucleotides
05/30/2002CA2429605A1 Indol derivative and their use as inhibitors of p38 kinase
05/30/2002CA2428459A1 Novel compounds for use as hiv protease inhibitors
05/30/2002CA2428191A1 Acid derivatives useful as serine protease inhibitors
05/30/2002CA2427334A1 Methods and compositions for the treatment of diseases of the eye
05/30/2002CA2427284A1 Antiinflammation agents
05/29/2002EP1208097A2 Substituted oxoazaheterocyclyl compounds
05/29/2002EP1208090A1 Herbicidaltetrazolinone derivatives
05/29/2002EP1207882A1 Acyclic and cyclic amine derivatives
05/29/2002CN1351602A New pharmaceutically active compounds
05/29/2002CN1351599A Indole-type derivatives as inhibitors of P38 kinase
05/29/2002CN1351595A Substituted polycyclic aryl and heteroacryl pyrazinones useful for selective inhibition of the coagulation cascade
05/29/2002CN1351592A Acyl derivatives which treat VL4-4 related disorders
05/29/2002CN1351590A Compounds
05/29/2002CN1351497A Aminopyrimidines as sorbitol dehydrogenase inhibitors
05/29/2002CN1350787A Synergistic herbicidal composition and method
05/29/2002CN1350786A Synergistic herbicidal composition and method
05/28/2002US6395767 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
05/28/2002US6395766 Cognition activators
05/28/2002US6395764 Nosal decongestion, respiratory system disorders
05/28/2002US6395753 Antihistamines, antiallergens, antiarthritic agents
05/28/2002US6395734 Anticancer agents
05/23/2002WO2002040507A2 Novel compounds for uses in radioimmunoscintigraphy and/or radioimmunotherapy of cancers
05/23/2002WO2002040488A1 Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photocynamic therapy
05/23/2002WO2002040473A1 Pyrimidine compounds or salts thereof, herbicides containing the compounds or the salts, methods for control of weeds by applying the same
05/23/2002WO2002040471A2 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
05/23/2002WO2002040470A1 Imidazole derivatives, process for their preparation and their use
05/23/2002WO2002040456A1 Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
05/23/2002WO2002040455A1 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars)
05/23/2002WO2002008203A3 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by vla-4
05/23/2002WO2001072707A3 Carbamate caspase inhibitors and uses thereof
05/23/2002WO2001030330A3 Method to treat pain utilizing benzimidazole nmda/nr2b antagonists
05/23/2002WO2000063204A3 Substituted azoles
05/23/2002US20020061923 Diacid isoindoleine amide derivative
05/23/2002US20020061922 Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
05/23/2002US20020061919 Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-{(2-methyl-1h-imidazol-1-yl)methyl}-4h-carbazol-4-one
05/23/2002US20020061917 Efficient process for the preparation of a factor Xa inhibitor
05/23/2002US20020061916 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
05/23/2002US20020061911 Enantiomers of 6-amino EM-12 and method of use
05/23/2002US20020061898 Inhibitors of nucleoside metabolism
05/23/2002US20020061891 Indole derivatives as 5-HT1B and 5-HT1D agonists
05/23/2002US20020061889 New pyridazine endothelin antagonists
05/23/2002US20020061877 Substituted cyclic amine metalloprotease inhibitors
05/23/2002DE10054019A1 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel New substituted indolinones, their preparation and their use as medicaments
05/23/2002CA2448729A1 Piperazinyl and piperidyl substituted heterocyclic compounds
05/23/2002CA2429437A1 Imidazole derivatives, process for their preparation and their use
05/23/2002CA2428844A1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
05/23/2002CA2428335A1 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars)
05/22/2002EP1207160A1 Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
05/22/2002EP1206703A1 Use of acylsulfonamido-substituted polymethine dyes as fluorescence dyes and/or markers
05/22/2002EP1206467A1 N-heterocyclic derivatives as nos inhibitors
05/22/2002EP1206444A1 Compounds that inhibit tryptase activity
05/22/2002EP1206265A1 Src kinase inhibitor compounds
05/22/2002EP1206260A1 Src kinase inhibitor compounds
05/22/2002EP0563238B1 Imidazolyl-alkenoic acids
05/22/2002CN1350533A New ECE inhibitors, their production and their use
05/22/2002CN1350530A 酰胺衍生物 Amide derivatives
05/22/2002CN1350523A Indoline derivatives as progesterohe antagonists
05/22/2002CN1350520A Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
05/22/2002CN1350476A Novel triazine-based detoxification agents and their use
05/22/2002CN1350458A Protease inhibitors
05/22/2002CN1349983A Non-peptide neomatal vascularization inhibitor
05/22/2002CN1085213C Triazole derivatives useful in therapy
05/21/2002US6392046 Aids therapy
05/21/2002US6391910 Opioid antagonist; analgesic
05/21/2002US6391907 Anticancer agents; contraceptives
05/21/2002US6391882 4,5,6 and 7-indole and indoline derivatitives, their preparation and use
05/21/2002US6391874 Anticarcinogenic agents; skin disorders
05/21/2002US6391064 Composition for hair dyeing comprising condensates of quinoline-5, 8-diones or of quinoxaline-5,8-diones and substituted pyrroles, anilines or indoles
05/16/2002WO2002038561A1 Indolylmaleimide derivatives as protein kinase c inhibitors
05/16/2002WO2002038553A2 Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists
05/16/2002WO2002038551A1 Pyrimidine derivatives and their use as neuropeptide y receptor ligands
05/16/2002WO2002038549A1 Hetero-anellated ortho-aminophenols and their use as dye components
05/16/2002WO2002038544A2 3-substituted oxindole beta 3 agonists
05/16/2002WO2002038543A2 3-substituted oxindole beta 3 agonists
05/16/2002WO2002038184A1 Oral pharmaceutical composition containing a block copolymer
05/16/2002WO2002030891A8 Aliphatic nitrogenous five-membered ring compounds
05/16/2002WO2002030890A8 Nitrogenous five-membered ring compounds
05/16/2002WO2002018339A3 Compounds useful as insecticides, compounds useful as acaricides, and processes to use and make same
05/16/2002WO2002010158A3 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
05/16/2002WO2001097790A3 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents
05/16/2002WO2001096295A3 2-cyanopyrrolidine derivatives and their use as medicaments
05/16/2002WO2001087287A3 Use of pyrazole derivatives for treating infertility
05/16/2002WO2001083465A3 Alkynyl phenyl heteroaromatic glucokinase activators
05/16/2002WO2001079198A9 Pyrazoles for inhibiting protein kinase
05/16/2002WO2001079195A3 Pyridine and pyrazine derivatives as thrombin inhibitors
05/16/2002WO2001007434A3 Indole derivatives and their use as 5ht2a ligands
05/16/2002US20020058816 For therapy of eating disorder, obesity, bulimia nervosa, diabetes, binge eating, anorexia nervosa, dyslipidimia, hypertension, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/ reproductive disorders, depression
05/16/2002US20020058813 Spiro-indolines as Y5 receptor antagonists
05/16/2002US20020058809 For therapy of autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, Crohn's disease, ulcerative colitis, multiple sclerosis, Guillain-Barre syndrome, psoriasis